GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (TSXV:IPCI) » Definitions » Inventory Turnover

IntelliPharmaCeutics International (TSXV:IPCI) Inventory Turnover : 0.00 (As of Aug. 2023)


View and export this data going back to 1999. Start your Free Trial

What is IntelliPharmaCeutics International Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. IntelliPharmaCeutics International's Cost of Goods Sold for the three months ended in Aug. 2023 was C$0.02 Mil. IntelliPharmaCeutics International's Average Total Inventories for the quarter that ended in Aug. 2023 was C$0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. IntelliPharmaCeutics International's Days Inventory for the three months ended in Aug. 2023 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. IntelliPharmaCeutics International's Inventory-to-Revenue for the quarter that ended in Aug. 2023 was 0.00.


IntelliPharmaCeutics International Inventory Turnover Historical Data

The historical data trend for IntelliPharmaCeutics International's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Inventory Turnover Chart

IntelliPharmaCeutics International Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.11 - - -

IntelliPharmaCeutics International Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

IntelliPharmaCeutics International Inventory Turnover Calculation

IntelliPharmaCeutics International's Inventory Turnover for the fiscal year that ended in Nov. 2022 is calculated as

Inventory Turnover (A: Nov. 2022 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Nov. 2022 ) / ((Total Inventories (A: Nov. 2021 ) + Total Inventories (A: Nov. 2022 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

IntelliPharmaCeutics International's Inventory Turnover for the quarter that ended in Aug. 2023 is calculated as

Inventory Turnover (Q: Aug. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Aug. 2023 ) / ((Total Inventories (Q: May. 2023 ) + Total Inventories (Q: Aug. 2023 )) / count )
=0.024 / ((0 + 0) / 1 )
=0.024 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IntelliPharmaCeutics International  (TSXV:IPCI) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

IntelliPharmaCeutics International's Days Inventory for the three months ended in Aug. 2023 is calculated as:

Days Inventory =Average Total Inventories (Q: Aug. 2023 )/Cost of Goods Sold (Q: Aug. 2023 )*Days in Period
=0/0.024*365 / 4
=0.00

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

IntelliPharmaCeutics International's Inventory to Revenue for the quarter that ended in Aug. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Aug. 2023 ) / Revenue (Q: Aug. 2023 )
=0 / 0.093
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


IntelliPharmaCeutics International Inventory Turnover Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


IntelliPharmaCeutics International (TSXV:IPCI) Business Description

Traded in Other Exchanges
Address
30 Worcester Road, Toronto, ON, CAN, M9W 5X2
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (TSXV:IPCI) Headlines

No Headlines